vimarsana.com
Home
Live Updates
Efficacy and Safety of Early Administration of 4-Factor Prothrombin Complex Concentrate in Patients With Trauma at Risk of Massive Transfusion: The PROCOAG Randomized Clinical Trial | Emergency Medicine | JAMA : vimarsana.com
Efficacy and Safety of Early Administration of 4-Factor Prothrombin Complex Concentrate in Patients With Trauma at Risk of Massive Transfusion: The PROCOAG Randomized Clinical Trial | Emergency Medicine | JAMA
This randomized clinical trial examines whether systematic 4-factor prothrombin complex concentrate administration combined with a ratio-based transfusion proto
Related Keywords
France ,
Helsinki ,
Eteläuomen Läi ,
Finland ,
Brussels ,
Bruxelles Capitale ,
Belgium ,
French ,
Olga Kroselj ,
Albert Michallon ,
Laura Leo ,
Jennifer Margier ,
Samir Yamani ,
Laboratoire Fran ,
Les Ullis ,
Fabio Silvio Taccone ,
Christopher Seymour ,
Pauline Manhes ,
Marion Richard ,
Audrey Lehmann ,
Pierre Bouzat ,
Edwards Lifesciences ,
Aline Baron ,
Fresenius ,
Grenoble Alpes University Hospital ,
Astrazeneca ,
Statistical Solutions Ltd ,
Department Of Anesthesiology ,
International Symposium On Intensive Care Emergency Medicine ,
Injury Severity Score ,
French Agency ,
Health Products ,
Agence Nationale ,
Des Produits De Sant ,
Saint Denis ,
Good Clinical Practice ,
Blood Consumption ,
Glasgow Outcome Scale Extended ,
Abbreviated Injury Scale ,
Size Estimation ,
Northern French Alps Registry ,
Sample Size ,
Power Calculation ,
Outcome Scale Extended ,
Associate Editor ,
Interest Disclosures ,
French Ministry ,
International Symposium ,
Intensive Care ,
Emergency Medicine ,
Pole Pharmacie ,
Critical Care ,
Erasme Hospital Belgium ,
vimarsana.com © 2020. All Rights Reserved.